Hemodynamic Changes after Continuing or Omitting Regular Angiotensin Converting Enzyme Inhibitors before Cataract...

Area of Science:

• Anesthesiology
• Cardiology
• Pharmacology

Background:

• Angiotensin Receptor Blockers (ARBs) and Angiotensin-Converting Enzyme Inhibitors (ACEIs) are commonly prescribed for cardiovascular conditions.
• Management of these medications around elective surgeries, particularly minor procedures like cataract surgery, requires careful consideration due to potential hemodynamic effects.

Purpose of the Study:

• To evaluate the impact of continuing versus discontinuing ARBs and ACEIs on hemodynamic parameters during and after cataract surgery.
• To determine if medication management strategies influence patient safety and outcomes in this surgical context.

Main Methods:

• A randomized study involving patients aged 40-70 (ASA class II) on ACEI/ARB therapy undergoing cataract surgery.
• Patients were divided into two groups: one continuing ACEI/ARB use and the other discontinuing it prior to surgery.
• Hemodynamic data (heart rate, systolic and diastolic blood pressure) were collected before, during, and after anesthesia induction.

Main Results:

• No significant differences were observed in demographic variables between the groups.
• While time significantly affected blood pressure and heart rate (p<0.001), there was no significant interaction between time and treatment group.
• Group effects on systolic blood pressure, diastolic blood pressure, and heart rate were not statistically significant (p > 0.05).

Conclusions:

• Continuing or discontinuing ACEIs/ARBs does not appear to significantly affect hemodynamic stability (hypotension, heart rate) in patients undergoing minor procedures like cataract surgery.
• These findings suggest that current practices for managing ACEI/ARB therapy around cataract surgery may be safe.
• Further research could explore other surgical types or patient populations.